Madeleine Johnson - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Madeleine Johnson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Madeleine Johnson

Madeleine Johnson

Verified

Reporter, GenomeWeb

New York

Final Covers

pregnant, newborn care, pregnancy risks childbearing, centering pregnancy,birthing midwifery, hospital care, infant health fathering, mothering, vaccinations women's health

Journalist Type

-

Seniority Positions

-

Industries

Medium Formats

-

Content

Total articles 390

  • Nuclein Advances Point-of-Care Test Menu for 15-Minute PCR System

    By Madeleine Johnson Verified| 360Dx Verified NEW YORK – Following CLIA waiver for its 15-minute qPCR system and combination COVID/influenza assay earlier this year, diagnostics developer Nuclein is further expanding into the point-of-care testing space with plans to begin clinical trials later this year for two new tests. Nuclein obtained 510(k) and CLIA waiver from the US Food and Drug Administration in January for its DASH system and a multiplex test to detect COVID-19, influenza A, and influenza B infections.

    By Madeleine Johnson Verified · 360Dx

    Apr. 11, 2025

  • As Digital PCR Expands into Oncology, More Clinical Diagnostic Applications on Horizon

    By Madeleine Johnson Verified| 360Dx Verified NEW YORK – While digital PCR has been around for more than three decades and has established itself as a valuable research tool, its use in clinical diagnostics had continued to be a goal more than a reality.

    By Madeleine Johnson Verified · 360Dx

    Apr. 09, 2025

  • Nuclein Advances Point-of-Care Test Menu for 15-Minute PCR System

    By Madeleine Johnson Verified| 360Dx Verified NEW YORK – Following CLIA waiver for its 15-minute qPCR system and combination COVID/influenza assay earlier this year, diagnostics developer Nuclein is further expanding into the point-of-care testing space with plans to begin clinical trials later this year for two new tests. Nuclein obtained 510(k) and CLIA waiver from the US Food and Drug Administration in January for its DASH system and a multiplex test to detect COVID-19, influenza A, and influenza B infections.

    By Madeleine Johnson Verified · 360Dx

    Apr. 11, 2025

As seen in

Company Info

GenomeWeb

GenomeWeb is an independent online news organization based in New York, established in 1997. It serves the global community of scientists, technology professionals, and executives involved in molecular biology research and molecular diagnostics. As a business unit of Crain Communications, GenomeWeb focuses on delivering comprehensive news coverage and in-depth analysis in the fields of genomics and molecular diagnostics. The organization operates the largest online newsroom dedicated to advanced molecular research tools, providing exclusive news and insights. Key offerings include detailed news and analysis of scientific advancements, premium content for subscribers, access to data centers and research reports, and newsletters to keep professionals updated on the latest developments. GenomeWeb's audience includes major scientific organizations, biopharmaceutical companies, research universities, and clinical labs, making it a vital resource in the genomics sector.

New York, New York, United States

+1 212-269-4747

Founded: 1997